aug 19. Initial Timeline (extracted from pdf)
aug 30. Ready to Begin
Alright, I can confirm that I will have all necessary supplies to move forward with the sword fern / hemlock
sequencing project by the end of next week.
Paul, which date works best for you to do field work? I would prefer Tuesday 9/10 so that I can immediately get
started on lab work the following day. If you'd like to go out sooner, Friday 9/6 would also be fine.
sep 25. Dylan Reports Adapter Problem
The 260/230 ratios should ideally be around 2.0, but I had values as low as 0.56 and 1.06. This is likely caused by
contamination from salts, proteins or cellulose.
Total DNA yield was adequate: 30 to 50 ng/ul. It should be 5 ng/ul at a minimum.
I think the poor quality is most likely the result of me overloading the reagents with more plant tissue than you're
supposed to use. I was trying to carefully follow Younginger's protocol, and his methods clearly indicate that he
extracted DNA from the entire pinna. But that meant that I was adding 3 to 12 times more tissue than is specified in the
current Qiagen kit protocol (50 to 100 mg). This may be a slightly different protocol than what Younginger used, which
has since been discontinued / updated.
Another contributing factor is probably the unique biochemistry of sword fern leaves - old perennial fronds that are
probably rich in phenols and complex organic compounds. DNA extraction from younger or softer plant tissue is
generally thought to be easier.
In terms of timeline, this probably looks like doing optimization work in October and extracting DNA / submitting
samples for sequencing in early to mid November.
Please let me know what you think of this plan or if you have any questions.
oct 4. Dylan Reports Extraction Problems
Background
I've been working with a small number of test samples from extra sword fern pinnae that I collected to make sure that
we're getting good results before using the kit on the actual samples. I measured the spectra of the DNA extracts and
calculated the 260/280 and 260/230 purity ratios. The values that I got were below the acceptable range which indicates
potential contamination. The concern is that these contaminants could be PCR inhibitors.
Findings
The 260/280 ratios for DNA should ideally be above 1.8. I had values range from 1.60 to 1.86, which indicates potential
contamination from proteins or phenols. Proteins would be inherited from the tissue samples. Phenols could be from the
plant tissue and/or from reagents that carried over from earlier steps in the workflow.
Next Steps
I'd like to do some further troubleshooting to optimize the protocol. This will involve varying the amount of tissue
used, and potentially augmenting other steps in the protocol. For example, the kit comes with a special solution that is
completely optional - it reduces overall yield but improves quality. If protocol optimization hasn't brought the purity
ratios back up to acceptable levels, I can also try some diagnostic PCR. If I'm able to create PCR products using the
same primers as Dalhousie, it doesn't matter much what the 260/280 or 260/230 values are. If it works, it works.
oct 11. Brief Project Update for FoSP meeting
oct 16. Hannah McConnell offers comments
Meeting / planning / engaging with these 3rd parties is outside the scope
of my contract. It would also significantly delay my lab work. At this
point, I don't have any specific questions for these people, so it seems a
bit unnecessary to spend time engaging with them. However, if it's
important to FoSP that I bring these folks into the project, I can
certainly make that happen. Would you like me to invoice at my hourly rate
for that work?
Otherwise, I plan on continuing the troubleshooting steps that I outlined
in my previous project update on 10/4, which Paul Talbert seemed to
approve of in his response to that email.
oct 21: Dylan declines
oct 21. pshannon summary sent to Dylan
oct 24. more from Hannah
Dylan's Protocol
Sorry to be slow to respond. I'm not sure where you are in your
trouble-shooting, but I see a number of differences in the DNeasy Plant Mini Kit
that Younginger used and the DNeasy Plant Pro kit you used, mostly having to do
with somewhat different buffers. Those seem unlikely to be the source of purity
problems to me. I think you are probably correct that overloading the tissue is
the likely reason for impurities. The other step I would look at carefully is
the tissue homogenization and disruption.
You say that the Younginger "methods clearly indicate that he extracted DNA
from the entire pinna." but I didn't find this to be entirely clear. He says
that he surface-sterilized pinnae and placed them in tubes for disruption of
"fresh tissue" in a Tissuelyzer II bead mill, "immediately preceding DNA
extraction... according to the manufacturer's instructions." Both the DNeasy
Plant Mini and DNeasy Plant Pro kits specify 100mg or less of wet tissue, so he
may have used less than an entire pinna. Regardless of whether he extracted DNA
from the entire pinna or from just 100 mg, I think I would try testing DNA
prepared from <100mg of tissue as recommended to see if that solves your
problem. It's possible that the Pro Kit may be more sensitive to the quantity of
material than the Mini Kit.
The Pro kit offers 3 methods of homogenization and I would guess that this is
a critical step for clean preps. The mini Kit recommends a Tissuelyzer II,
Tissue Ruptor, or a mortar and pestle, but Younginger says he used the
Tissuelyzer II. I haven't used these kits so I am not sure how this step works,
and you don't mention which method you used. The Tissuelyzer II and Powerlyzer
24 Homogenizer appear to be a separate pieces of (probably expensive)
equipment. Do you have access to one of these, or did you use the vortex method?
Grinding tissue with a mortar and pestle is used in a lot of different DNA
preps, but you'd need liquid nitrogen and this is usually used for larger
quantities (grams, not milligrams) of tissue than just an individual pinna, so
I'm not sure that would be a good choice even if it were recommended in the Pro
kit.
You also mention that you could do a PCR test to see if you get products (of
the expected size). If you have the primers, this seems like a quick one-day way
of seeing if your samples are sufficiently pure.
Calling Qiagen customer service wouldn't hurt either. Sometimes they have no
better idea than you do , but other times they may know how to help, or at least
be a sounding board for your ideas of how to trouble shoot. They probably have
the best information about differences between the two kits, homogenization
methods, and tissue quantities.
Let me know if I can be of help.
oct 28: Paul Talbert Discusses Protocols
Will you clarify something for me? (just me, I took the rest off the address list)
oct 28: Liz V's questions for Paul Talbert
I never have done this sort of work, so although I can follow the biochemistry
of a protocol, I don't know the overall steps, or exactly what Dylan is supposed
to do himself, before the product from Dylan gets sent somewhere else.
I'm back from my conference and ready to make more progress on this
project. Could you please clarify - are you all interested in organizing a
meeting with one of those other biologists that Paul Shannon was in touch with?
I don't want to waste time troubleshooting the extraction protocol if our
approach is going to potentially change after that meeting.
Nov 4: Dylan replies to Paul Talbert
From my point of view, the suggestion of talking with Hannah from the di
Stilio lab was to save you time in optimizing your protocol. That lab has
been extracting fern DNA for some time.
But --- it's possible you will be able to optimize by one or two more runs
through your own protocol, so consulting the other lab may not be
necessary.
I believe Paul Talbert will or has been in touch with you about talking via
Zoom, to offer help and see where you are at this moment in the
process(es),
So, I'll wait to hear more from Paul T and from you if I'm included.
Nov 4: Liz to Dylan
I mentioned this at the meeting on Saturday, but after discussion, and (I think) some general agreement, I failed to make a formal motion.
Which could be this:
We ask Paul Talbert to specify for Dylan, approximately this:
This is a fair amount of fuss, for which I apologize. It is worthwhile, in some form, however: this check on the extraction process raises the odds of a successful sequencing project.
Nov 13: email to board from Paul Shannon
I propose this for board discussion and a vote. Which probably needs
to wait for the December 14th meeting, since I failed to get this on
11/9. Perhaps Paul Talbert can inform Dylan, a bit more formally than
he already has, that these are our expectations? Perhaps we do not
need a vote.
May I return this to your attention? Only Chris Hollinger has responded thus far.
As board members we have the commonsense obligation, and likely also the fiduciary responsibility, to manage the sword fern endophyte sequencing contract with care. 25% of our bank account is involved.
You may reject my proposal. Or suggest modifications. All that is fine, of course. Let democracy - our collective views - work this out.
Please let us know your position!
Nov 17: Paul Shannon's followup email
Nov 20: Dylan reports to Paul Talbert
I didn't hear back from Brett Younginger, but I'm not too surprised
given how busy he is these days. I did talk to Qiagen customer service
though. They had several encouraging suggestions:
I've also reached out to the sequencing vendor to check what their
quality control requirements are. Even if we can show that we can do
PCR, they still might not accept the DNA extracts (I wouldn't if I
was them). It's possible they will require us to send purified PCR
products, in which case I will need to order a PCR cleanup
kit. These are fairly expensive, so I would like to first see if the
suggestions from Qiagen improve the 260/280 and 260/230 values.
I'm hoping to put in another lab day the week of December 16, but I'm
pretty slammed with end of year reporting right now, so I might not be
able to do more lab troubleshooting until early January when my
schedule opens up.
Dec 8: Dylan's monthly report
The person that I talked to said that the low 260/230 values might not
be very meaningful, especially at relatively low yields such as
this. She also thought it was less likely to be polyphenol
contamination, and more likely to be residual ethanol. In any case,
she suggested trying out PCR and if it works, it works.
Last week, I ran two PCR programs designed to carefully follow the
vendor's workflow. In this case, I used their same primers to target
the 16S region. I also included a rigorous positive control from a
bacteria mock community standard and a negative control.
Unfortunately, I'm having trouble imaging the gels, so I can't confirm
that the PCR worked yet. I think it's a problem with the DNA dyes that
I purchased for this project. The reason that I'm confident it's a
problem with the dye is that I can barely see the DNA ladder, even
when I load the gel with 6x the concentration that I normally use.
So my next step is to order a different DNA stain and try again.
I realize this is probably not the level of progress that you were
hoping for. If you prefer, we can cancel the rest of the
contract. However, I thought you should know that I will be continuing
this troubleshooting regardless, because I also have samples from
Mercer Island to sequence.
Please let me know if you have any questions or suggestions.
Yours,Feb 4, 2025: Dylan's last email, contract cancellation
offered
Hello Paul,
Dylan Mendenhall
Founder | Ecologist
Haven Ecology and Research LLC
Email: dylan@havenecology.com
Cell: 206.225.4277
Feb 8, 2025: Contract suspended
[This note is reconstructed from memory by Paul Shannon, 2 jun 2025]
At the February 8th FoSP meeting, the
board voted to suspend Dylan's project, due to lack of progress,
missed milestones, his lukewarm (at best) pursuit of solutions to obstacles he
has encountered.